The research and development (R&D) team at a pharmaceutical company is developing a drug for colon cancer. Which of the following is true of the R&D costs incurred in developing this drug during the current year? Multiple Choice They are expensed directly in the income statement. They are expensed in the period in which benefits from R&D accrue. They are recorded as an intangible asset in the balance sheet